Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-10T17:13:47.398Z Has data issue: true hasContentIssue false

7 - Pharmacological management of spasticity

Published online by Cambridge University Press:  22 August 2009

Anthony B. Ward
Affiliation:
Consultant in Rehabilitation Medicine North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire, Stoke-on-Trent, UK
Sajida Javaid
Affiliation:
Specialist Registrar in Rehabilitation Medicine North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire, Stoke-on-Trent, UK
Michael P. Barnes
Affiliation:
University of Newcastle upon Tyne
Garth R. Johnson
Affiliation:
University of Newcastle upon Tyne
Get access

Summary

Introduction

The management of spasticity requires a multiprofessional approach and is based on addressing the troublesome effects of the increased tone. Nursing staff have a considerable role in this context along with physiotherapists, occupational therapists, speech and language therapists and doctors. The essential treatment of spasticity is physical. Even when pharmacological agents are used, physical treatment strategies should be in place and pharmacological interventions should be regarded as adjunctive rather than as substitutes for physical management (Ward et al., 1997).

Spasticity may not be harmful, particularly in early rehabilitation after an injury to the brain or spinal cord, where it may be utilized to improve functioning. For example, a spastic leg with minimal motor control may be a useful prop after a stroke to allow a stand pivot transfer and weight bearing. Treatment should be clearly set within the context of goals for rehabilitation (Ward et al., 1997). Even in patients who develop this impairment without much disability, treatment goals should be documented and agreed on with the patient and carers. Spasticity is not a condition that needs treatment in its own right and, indeed, medication may sometimes result in systemic side effects producing greater impairment. There are several situations in which spasticity reduction would serve no valid functional goal. For example, a patient with severe spasticity and poor selective motor control but whose spasticity is not painful and not interfering with care or positioning may not experience any improvement after tone reduction.

Type
Chapter
Information
Upper Motor Neurone Syndrome and Spasticity
Clinical Management and Neurophysiology
, pp. 131 - 149
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Pharmacological management of spasticity
    • By Anthony B. Ward, Consultant in Rehabilitation Medicine North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire, Stoke-on-Trent, UK, Sajida Javaid, Specialist Registrar in Rehabilitation Medicine North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire, Stoke-on-Trent, UK
  • Edited by Michael P. Barnes, University of Newcastle upon Tyne, Garth R. Johnson, University of Newcastle upon Tyne
  • Book: Upper Motor Neurone Syndrome and Spasticity
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544866.008
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Pharmacological management of spasticity
    • By Anthony B. Ward, Consultant in Rehabilitation Medicine North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire, Stoke-on-Trent, UK, Sajida Javaid, Specialist Registrar in Rehabilitation Medicine North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire, Stoke-on-Trent, UK
  • Edited by Michael P. Barnes, University of Newcastle upon Tyne, Garth R. Johnson, University of Newcastle upon Tyne
  • Book: Upper Motor Neurone Syndrome and Spasticity
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544866.008
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Pharmacological management of spasticity
    • By Anthony B. Ward, Consultant in Rehabilitation Medicine North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire, Stoke-on-Trent, UK, Sajida Javaid, Specialist Registrar in Rehabilitation Medicine North Staffordshire Rehabilitation Centre, University Hospital of North Staffordshire, Stoke-on-Trent, UK
  • Edited by Michael P. Barnes, University of Newcastle upon Tyne, Garth R. Johnson, University of Newcastle upon Tyne
  • Book: Upper Motor Neurone Syndrome and Spasticity
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544866.008
Available formats
×